Literature DB >> 75930

Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B.

P Anderson.   

Abstract

The capsular polysaccharide of Haemophilus influenzae type b was intrinsically labeled with tritium by a microculture technique with 6-3H-D-glucose and was isolated in radioantigenically pure form by a combination of selective precipitation and molecular sieve chromatography. Labeling with tritated sugar residues approached one-fourth maximum and produced a specific activity 10-fold that previously described for extrinsic labeling methods. In radioantigen-binding assays for antibody, sensitivity depended on the size of the antigen; preparations were readily made that could detect 0.01 microgram Ab/ml in serum samples of 25 microliter. Stability of the labeled antigen appears limited only by the primary radiodecomposition of tritium.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 75930

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.

Authors:  G Tudor-Williams; J Frankland; D Isaacs; R T Mayon-White; J A MacFarlane; D G Rees; E R Moxon
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

2.  Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines.

Authors:  Thomas J Inzana; Anna Champion
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

3.  A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b.

Authors:  M Mariani; E Luzzi; D Proietti; S Mancianti; D Casini; P Costantino; P van Gageldonk; G Berbers
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  Haemophilus influenzae type b infection after nephrotic syndrome in a previously vaccinated child.

Authors:  U Allen; E Wang
Journal:  CMAJ       Date:  1989-08-15       Impact factor: 8.262

5.  Detection of serotype-specific antibodies or capsular antigen of Actinobacillus pleuropneumoniae by a double-label radioimmunoassay.

Authors:  T J Inzana; G F Clark; J Todd
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Multiple mechanisms in serum factor-induced resistance of Haemophilus influenzae type b to antibody.

Authors:  M Kuratana; E J Hansen; P Anderson
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

7.  Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.

Authors:  D V Madore; P Anderson; B D Baxter; G M Carlone; K M Edwards; R G Hamilton; P Holder; H Käyhty; D C Phipps; C C Peeters; R Schneerson; G R Siber; J I Ward; C E Frasch
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

8.  A mucosal antibody response following systemic Haemophilus influenzae type B infection in children.

Authors:  M E Pichichero; C B Hall; R A Insel
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

9.  Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

10.  Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.

Authors:  M T Jelonek; S J Chang; C Y Chiu; M K Park; M H Nahm; J I Ward
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.